Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$1.42B |
| 2 |
FedEx
FDX
|
+$1.05B |
| 3 |
Intel
INTC
|
+$848M |
| 4 |
Celanese
CE
|
+$743M |
| 5 |
RTX Corp
RTX
|
+$741M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$1.73B |
| 2 |
Comcast
CMCSA
|
+$1.5B |
| 3 |
Crown Castle
CCI
|
+$1.33B |
| 4 |
UnitedHealth
UNH
|
+$1.09B |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.7% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 13.81% |
| 4 | Industrials | 12.74% |
| 5 | Communication Services | 10.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
L3Harris
LHX
$53.5B
| $862K | ﹤0.01% |
4,953
-1,686
| -25% | -$310K |
|
427
Capital Group Global Growth Equity ETF
CGGO
$12.1B
| $736K | ﹤0.01% |
32,120
-724
| -2% | -$17.4K |
|
428
Capital Group Growth ETF
CGGR
$25.2B
| $506K | ﹤0.01% |
20,671
-53
| -0.3% | -$1.34K |
|
429
Capital Group Core Equity ETF
CGUS
$11.9B
| $411K | ﹤0.01% |
16,382
+1,382
| +9% | +$35.8K |
|
430
Diebold Nixdorf
DBD
$2.46B
| $346K | ﹤0.01% |
+18,269
| New | +$347K |
|
431
Vanguard FTSE All-World ex-US ETF
VEU
$70.6B
| $323K | ﹤0.01% |
6,201
+1,780
| +40% | +$96.3K |
|
432
Sociedad Química y Minera de Chile
SQM
$20.8B
| $252K | ﹤0.01% |
4,218
-3,495,844
| -100% | -$236M |
|
433
Momentus Inc Warrant
MNTSW
| $22.3K | ﹤0.01% |
2,225,000
| – | – |
|
434
Aptiv
APTV
$10.1B
| – | – |
-129,916
| Closed | -$13.3M |
|
435
Walt Disney
DIS
$180B
| – | – |
-2,682,873
| Closed | -$240M |
|
436
DexCom
DXCM
$34.5B
| – | – |
-2,340,342
| Closed | -$301M |
|
437
Enbridge
ENB
$112B
| – | – |
-1,482,712
| Closed | -$55.1M |
|
438
Enphase Energy
ENPH
$5.31B
| – | – |
-724,859
| Closed | -$121M |
|
439
Exelon
EXC
$46.9B
| – | – |
-3,628,215
| Closed | -$148M |
|
440
Gilead Sciences
GILD
$170B
| – | – |
-6,864
| Closed | -$529K |
|
|
441
Humana
HUM
$46.1B
| – | – |
-3,871,317
| Closed | -$1.73B |
|
442
Infosys
INFY
$49.5B
| – | – |
-9,852,748
| Closed | -$158M |
|
443
iShares Core S&P 500 ETF
IVV
$908B
| – | – |
-1,537
| Closed | -$677K |
|
444
Lockheed Martin
LMT
$138B
| – | – |
-162,317
| Closed | -$74.7M |
|
445
MaxLinear
MXL
$6.95B
| – | – |
-328,275
| Closed | -$10.4M |
|
446
Nexa Resources
NEXA
$1.9B
| – | – |
-4,709,938
| Closed | -$22.9M |
|
447
NVR
NVR
$17B
| – | – |
-24,677
| Closed | -$157M |
|
448
Ultragenyx Pharmaceutical
RARE
$2.64B
| – | – |
-967,357
| Closed | -$44.6M |
|
449
Thermo Fisher Scientific
TMO
$222B
| – | – |
-43,231
| Closed | -$22.6M |
|
450
Travelers Companies
TRV
$77B
| – | – |
-372,347
| Closed | -$64.7M |
|
Similar funds
Capital International Investors's Q3 2023 Portfolio in Review
As of Q3 2023, Capital International Investors held 454 positions worth $394B, down 4.9% from $414B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Capital International Investors's Q3 2023 filing shows 19 new, 197 increased, 163 reduced and 20 closed positions. Its largest new stake was Ingersoll Rand: 9,043,508 shares worth $576M. The largest sale was Humana, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- Capital International Investors's largest Q3 2023 buy was Ingersoll Rand: 9,043,508 shares worth $576M.
- Capital International Investors added most to CVS Health in Q3 2023, an estimated $1.42B increase.
- Capital International Investors's biggest Q3 2023 reduction was Comcast, cutting an estimated $1.5B.
- Capital International Investors fully exited Humana in Q3 2023, selling an estimated $1.73B.
- Capital International Investors's ten largest holdings make up 27% of its $394B portfolio in Q3 2023.
- Capital International Investors opened 19 new positions and closed 20 in Q3 2023.
- Capital International Investors's portfolio value fell 4.9% quarter-over-quarter to $394B.
Based on Capital International Investors's 13F filing for Q3 2023, filed 13 Nov 2023.